Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pregnancy after lupus nephritis.

G Moroni1, C Ponticelli

  • 1Unita' Operativa di Nefrologia, IRCCS Ospedale Maggiore Policlinico, Milano, Italy. croff1@policlinico.mi.it

Lupus
|March 1, 2005
PubMed
Summary

Pregnancy is generally safe for most women with systemic lupus erythematosus (SLE) if planned during remission. However, fetal risks remain higher than in healthy pregnancies, especially with antiphospholipid antibodies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel markers of graft outcome in a cohort of kidney transplanted patients: a cohort observational study.

Journal of nephrology·2019
Same author

Should we really STOP treating patients with IgA nephropathy with steroids?

Physiology international·2018
Same author

Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.

Journal of nephrology·2017
Same author

Synthetic pharmacotherapy for lupus nephritis.

Expert opinion on pharmacotherapy·2017
Same author

Hydroxychloroquine in systemic lupus erythematosus (SLE).

Expert opinion on drug safety·2016
Same author

Predictors of renal survival in ANCA-associated vasculitis. Validation of a histopatological classification schema and review of the literature.

Clinical and experimental rheumatology·2015

Area of Science:

  • Immunology
  • Rheumatology
  • Obstetrics & Gynecology

Background:

  • Systemic lupus erythematosus (SLE) is an autoimmune condition predominantly affecting women of reproductive age.
  • Pregnancy in SLE patients presents complex challenges regarding maternal and fetal outcomes.
  • Sex hormone fluctuations during pregnancy may significantly impact SLE activity.

Purpose of the Study:

  • To evaluate the influence of pregnancy on SLE disease activity.
  • To assess the impact of SLE on pregnancy outcomes, including fetal health.
  • To review current understanding of risks and safety for SLE patients planning pregnancy.

Main Methods:

  • Review of historical and recent prospective studies on pregnancy in SLE patients.
  • Analysis of maternal and fetal outcomes in relation to SLE disease activity and specific autoantibodies.
  • Examination of the role of hormonal changes during pregnancy on SLE.

Main Results:

  • Pregnancy is safe for most SLE patients if planned during quiescent disease periods.
  • While maternal risks have decreased, fetal risks remain elevated compared to healthy pregnancies.
  • Antiphospholipid antibodies significantly increase the risk of adverse fetal outcomes.

Conclusions:

  • Planned pregnancies in quiescent SLE are generally safe for mothers.
  • Continuous monitoring and management are crucial for reducing fetal risks in SLE pregnancies.
  • Understanding the interplay between SLE, hormones, and pregnancy is key for improved patient care.

Related Experiment Videos